Ilaria Cerroni
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.
Journal: British journal of haematology
Published: February 25, 2026
Measurable residual disease as an actionable biomarker in acute myeloid leukemia. Ready or not?
Journal: Current opinion in oncology
Published: October 01, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.
Journal: Cancers
Published: May 13, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response.
Journal: Journal of clinical medicine
Published: January 28, 2025
Culprit or innocent bystander? The case of a new fast-moving hemoglobin J variant in a pregnant woman.
Journal: Blood cells, molecules & diseases
Published: January 18, 2025
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation.
Journal: Current research in translational medicine
Published: March 26, 2024
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge.
Journal: Current research in translational medicine
Published: November 06, 2023
Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML Patients.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 10, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026